Insmed, Inc. (NASDAQ:INSM)
CAPS Rating:
A biopharmaceutical company focused on the development and commercialization of drugs to treat metabolic diseases, endocrine disorders and oncology within niche markets that have unmet medical needs.
RSS Headlines
Fool UK